Cargando…

Multi-targeted anti-inflammatory drugs for the treatment of neurological disorders

Detalles Bibliográficos
Autores principales:	Lui, Austin, Alzayat, Omar, Do, Timothy, Perekopskiy, David, Gann, Meghan, Elgokhy, Taiseer Saad, Gao, Jie, Liu, DaZhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700111/ https://www.ncbi.nlm.nih.gov/pubmed/36204844 http://dx.doi.org/10.4103/1673-5374.353489

Ejemplares similares

FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders
por: Lui, Austin, et al.
Publicado: (2022)

Repurposing cancer drugs to treat neurological diseases – Src inhibitors as examples
por: Liu, Da Zhi
Publicado: (2017)

Anti-inflammatory properties of the glial scar
por: Gesteira, Tarsis F., et al.
Publicado: (2016)

Neurological Dysfunction in Long COVID Should Not Be Labelled as Functional Neurological Disorder
por: Van der Feltz-Cornelis, Christina M., et al.
Publicado: (2023)

Pesticides and Neurologic Symptoms
por: Burns, Carol, et al.
Publicado: (2005)

Could mammalian inorganic polyphosphate be a crucial signaling molecule in neurological disorders?
por: Da Costa, Renata Torres, et al.
Publicado: (2023)

Inflammatory Genomics
por: Gant, Timothy W.
Publicado: (2005)

Combining anti-inflammatory and unfolding protein responses to fight stroke
por: Anuncibay-Soto, Berta, et al.
Publicado: (2019)

Continued development of azithromycin as a neuroprotective therapeutic for the treatment of spinal cord injury and other neurological conditions
por: Kopper, Timothy J., et al.
Publicado: (2020)

Implications of Withaferin A in neurological disorders
por: Ram, Natasha, et al.
Publicado: (2020)

Transcranial electrical stimulation in neurological disease
por: Brown, Gregory L., et al.
Publicado: (2022)

Repurposing niclosamide for the treatment of neurological disorders
por: Apolloni, Savina, et al.
Publicado: (2023)

Neurological and Behavioral Consequences of Childhood Lead Exposure
por: Bellinger, David C
Publicado: (2008)

Lifting the mask on neurological manifestations of COVID-19
por: Pezzini, Alessandro, et al.
Publicado: (2020)

Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19
por: Pantelis, Christos, et al.
Publicado: (2020)

Osteoarthritis guidelines: a progressive role for topical nonsteroidal anti-inflammatory drugs
por: Stanos, Steven P
Publicado: (2013)

Evidences of hydroxytyrosol as an anti-inflammatory agent in Parkinson’s disease: insights into the mechanisms of action
por: Hornedo-Ortega, Ruth, et al.
Publicado: (2020)

Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
por: Bindu, Samik, et al.
Publicado: (2020)

Pesticides and Neurologic Symptoms: Kamel et al. Respond
por: Kamel, Freya, et al.
Publicado: (2005)

Pharmacological inhibition of cation-chloride cotransporters for neurological diseases
por: Nepomuceno, Rachel, et al.
Publicado: (2015)

Recent advances in RNA-targeting therapy for neurological diseases
por: Kumar, Satheesh, et al.
Publicado: (2023)

A Multi-Objective Approach for Anti-Osteosarcoma Cancer Agents Discovery through Drug Repurposing
por: Cabrera-Andrade, Alejandro, et al.
Publicado: (2020)

Hypertonic saline: a brief overview of hemodynamic response and anti-inflammatory properties in head injury
por: de Oliveira, Matheus Fernandes, et al.
Publicado: (2015)

Non-steroidal anti-inflammatory drugs (NSAIDs) and neuroprotection in the elderly: a view from the mitochondria
por: Calvo-Rodríguez, María, et al.
Publicado: (2015)

Exosomes in neurological disease, neuroprotection, repair and therapeutics: problems and perspectives
por: Kalani, Anuradha, et al.
Publicado: (2015)

N-acetyl proline-glycine-proline: implications for neurological disorders
por: Hill, Jeff W., et al.
Publicado: (2016)

Identification of neurological disease targets of natural products by computational screening
por: Konc, Janez
Publicado: (2019)

Progress in mimicking brain microenvironments to understand and treat neurological disorders
por: Ngo, Mai T., et al.
Publicado: (2021)

The unexpected science of estrogen receptor-β selective agonists: a new class of anti-inflammatory agents?
por: Harris, Heather A.
Publicado: (2006)

Potential Role of Nrf2 Activators with Dual Antiviral and Anti-Inflammatory Properties in the Management of Viral Pneumonia
por: Lin, Chih-Yin, et al.
Publicado: (2020)

Potential Utility of Ultrasound-Enhanced Delivery of Antibiotics, Anti-Inflammatory Agents, and Nutraceuticals: A Mini Review
por: Ead, J. Karim, et al.
Publicado: (2022)

Lipid mediators of inflammation in neurological injury: shifting the balance toward resolution
por: Harrison, Jordan L., et al.
Publicado: (2016)

Reactive astrocytes promote axonal remodeling and neurological recovery after stroke
por: Liu, Zhongwu, et al.
Publicado: (2014)

Multiple facets of poly(ADP-ribose) polymerase-1 in neurological diseases
por: Sriram, Chandra Shaker, et al.
Publicado: (2015)

Studying neurological disorders using induced pluripotent stem cells and optogenetics
por: Chin, Eunice W.M., et al.
Publicado: (2015)

Advancing mesenchymal stem/stromal cells-based therapies for neurologic disease
por: Phinney, Donald G.
Publicado: (2017)

Genetic testing in neurology exploiting next generation sequencing: state of art
por: Di Resta, Chiara, et al.
Publicado: (2019)

Disease-directed engineering for physiology-driven treatment interventions in neurological disorders
por: Wood, Thomas, et al.
Publicado: (2019)

Augmentation of transforming growth factor-β signaling for the treatment of neurological disorders
por: Luo, Jian
Publicado: (2023)

Animal models to study the neurological manifestations of the post-COVID-19 condition
por: Usai, Carla, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cq7377cak83pafd1ia9hub7n66